FDLI's Interagency Coordination Regarding Medical Products: The Effect on Coverage, Payment, Fraud and Abuse
September 12, 2011Washington, DC
3:00-4:00 p.m.
Superiority Claim Implications for "Comparative Effectiveness" and "Outcomes-Based Reimbursement"
PAREXEL Speaker:
Charles A. Stevens, JD, MBA,
Vice President & General Manager
Commercialization Strategy Services
PAREXEL International, Inc.
This session's speakers will suggest how companies should prepare to either accommodate or respond to "comparative effectiveness" outcomes. Speakers will also explore potential legal issues raised by a company's activities related to "comparative effectiveness" such as the potential risk of making inadvertent superiority claims or representations in discussions about "outcomes-based" reimbursement.
- Evaluate and discuss superiority claim implications for "comparative effectiveness"
- Describe "outcomes-based" reimbursement
Please use link to event web site to see full agenda.
PAREXEL Speakers Bureau
PAREXEL is your reliable source for knowledgeable speakers on issues affecting the pharmaceutical, biological, and medical device industries.
In addition to being leading subject matter experts, members of the PAREXEL team are experienced at delivering lively and compelling presentations to a broad range of audiences. If you need a speaker for an upcoming event, please click here.